What it is
MOTS-C is a small peptide encoded by mitochondrial DNA. It is studied for its role in metabolic regulation, insulin sensitivity, and exercise physiology. Preclinical and early human data suggest it acts as a metabolic signaling peptide — communicating between mitochondria and the rest of the cell.
MOTS-C is not an FDA-approved pharmaceutical. It is compounded for off-label use under physician supervision. Human clinical data is more limited than for some other peptides, and Dr. Brown will be transparent about what is and is not known when discussing whether a protocol makes sense for you.
How Dr. Brown approaches it
Peptide therapy at Esvie begins with a clinical consultation, not a phone order. Dr. Brown reviews your history, baseline labs where appropriate, the indication for treatment, and any contraindications before MOTS-C is prescribed.
If MOTS-C is appropriate, a written protocol — dose, frequency, duration, and monitoring plan — is provided. The peptide is sourced from a licensed compounding pharmacy. Protocols typically run four to eight weeks with structured breaks.
MOTS-C is most useful when integrated with the rest of a metabolic plan — exercise, nutrition, sleep, and other clinical care. It is not a substitute for that work.
What to expect
Consultation: An in-person visit with Dr. Brown. Medical history, baseline metabolic labs as indicated, and a discussion of realistic outcomes.
Treatment cycle: Subcutaneous injection on a schedule appropriate to the protocol. Most patients self-administer at home after instruction.
Monitoring: Check-ins through the cycle. Repeat labs as indicated to assess response and safety.
No downtime, no aftercare: Injection sites may be mildly tender briefly; nothing more.
Candidacy
Good candidates have a defined metabolic concern under physician care and are willing to integrate peptide therapy with the lifestyle work that makes it effective.
Not a candidate if you are pregnant or nursing. Not a candidate with active untreated malignancy. Not a candidate with uncontrolled diabetes that requires formal endocrine care. Not a candidate looking for a peptide to replace exercise, nutrition, or first-line medical management.
If MOTS-C is not appropriate, Dr. Brown will say so and discuss the alternatives that fit your situation.